Table 3.
SUCRA values of different interventions for outcomes.
| Clinical effectiveness rate |
Performance status | Leucopenia | Gastrointestinal reactions | Radiation esophagitis | 1-year survival rate | 2-year survival rate | |
|---|---|---|---|---|---|---|---|
| AD+RT | 24.87% | 47.17% | 44.15% | 36.56% | 42.9% | 52.8% | NR |
| RT | 3.59% | 0.44% | 10.75% | 24.23% | 10.00% | 3.51% | 12.65% |
| AI+RT | 62.53% | NR | NR | NR | 70.81% | NR | NR |
| AP+RT | 60.61% | 71.3% | NR | NR | NR | NR | NR |
| CKS+RT | 79.32% | 78.05% | 64.84% | 65.84% | 91.44% | 38.04% | 50.06% |
| DC+RT | 76.26% | NR | NR | NR | NR | NR | NR |
| EL+RT | 69.2% | NR | 10.93% | 20.96% | 18.19% | 32.83% | 30.32% |
| HCS+RT | 61.28% | NR | 31.47% | NR | 57.83% | 75.22% | 79.08% |
| JOE+RT | 51.48% | 28.97% | 62.08% | 60.53% | 58.31% | 52.83% | 49.9% |
| KA+RT | 31.44% | 59.33% | 73.28% | 53.61% | 55.86% | 70.63% | 77.98% |
| LE+RT | 44.52% | 64.74% | 84.72% | NR | NR | NR | NR |
| SM+RT | 34.89% | NR | 39.95% | NR | 44.65% | 38.63% | NR |
| SQFZ+RT | NR | NR | 77.83% | 88.26% | NR | 85.52% | NR |